Investment Analysts’ Updated EPS Estimates for December 3rd (ABSI, ACN, AMZN, APGE, APTO, ARGX, ATYR, BCTX, BGNE, BNTC)

Investment Analysts’ updated eps estimates for Tuesday, December 3rd:

Absci (NASDAQ:ABSI) had its buy rating reaffirmed by analysts at Guggenheim. They currently have a $10.00 target price on the stock.

Accenture (NYSE:ACN) had its neutral rating reiterated by analysts at Robert W. Baird. The firm currently has a $370.00 price target on the stock.

Amazon.com (NASDAQ:AMZN) had its outperform rating reaffirmed by analysts at BMO Capital Markets. BMO Capital Markets currently has a $236.00 target price on the stock.

Apogee Therapeutics (NASDAQ:APGE) had its buy rating reaffirmed by analysts at Guggenheim. They currently have a $110.00 target price on the stock, up from their previous target price of $95.00.

Aptose Biosciences (NASDAQ:APTO) (TSE:APS) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $2.00 target price on the stock.

argenx (NASDAQ:ARGX) had its outperform rating reissued by analysts at Wedbush. They currently have a $655.00 price target on the stock.

Atyr PHARMA (NASDAQ:ATYR) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $35.00 price target on the stock.

BriaCell Therapeutics (NASDAQ:BCTX) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $15.00 price target on the stock.

BeiGene (NASDAQ:BGNE) had its overweight rating reiterated by analysts at Morgan Stanley. They currently have a $300.00 price target on the stock.

Benitec Biopharma (NASDAQ:BNTC) had its buy rating reaffirmed by analysts at Guggenheim. Guggenheim currently has a $17.00 target price on the stock.

CleanSpark (NASDAQ:CLSK) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $27.00 price target on the stock.

Compass (NYSE:COMP) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $8.00 target price on the stock.

Credo Technology Group (NASDAQ:CRDO) had its buy rating reiterated by analysts at Stifel Nicolaus. They currently have a $75.00 price target on the stock, up from their previous price target of $50.00.

Salesforce (NYSE:CRM) had its market outperform rating reissued by analysts at JMP Securities. The firm currently has a $450.00 price target on the stock.

Enlivex Therapeutics (NASDAQ:ENLV) had its buy rating reaffirmed by analysts at D. Boral Capital. The firm currently has a $13.00 price target on the stock.

EQT (NYSE:EQT) had its sector perform rating reissued by analysts at Royal Bank of Canada. The firm currently has a $49.00 target price on the stock.

Esperion Therapeutics (NASDAQ:ESPR) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $16.00 target price on the stock.

Femasys (NASDAQ:FEMY) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $12.00 price target on the stock.

Green Brick Partners (NASDAQ:GRBK) had its market perform rating reaffirmed by analysts at JMP Securities.

Haemonetics (NYSE:HAE) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $112.00 price target on the stock.

HIVE Digital Technologies (NASDAQ:HIVE) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $8.00 target price on the stock.

Honeywell International (NASDAQ:HON) had its sector perform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $253.00 price target on the stock.

Intel (NASDAQ:INTC) had its underperform rating reaffirmed by analysts at Bank of America Co.. The firm currently has a $21.00 price target on the stock.

Inter Parfums (NASDAQ:IPAR) had its buy rating reaffirmed by analysts at DA Davidson. The firm currently has a $163.00 target price on the stock.

iRhythm Technologies (NASDAQ:IRTC) had its equal weight rating reaffirmed by analysts at Wells Fargo & Company. The firm currently has a $86.00 price target on the stock.

Integer (NYSE:ITGR) had its overweight rating reissued by analysts at Wells Fargo & Company. They currently have a $160.00 target price on the stock.

Jacobs Solutions (NYSE:J) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $152.00 target price on the stock.

Janux Therapeutics (NASDAQ:JANX) had its outperform rating reiterated by analysts at William Blair.

Microchip Technology (NASDAQ:MCHP) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $85.00 price target on the stock.

Merus (NASDAQ:MRUS) had its buy rating reiterated by analysts at Guggenheim. The firm currently has a $109.00 price target on the stock, down from their previous price target of $111.00.

Ocular Therapeutix (NASDAQ:OCUL) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $15.00 price target on the stock.

PROCEPT BioRobotics (NASDAQ:PRCT) had its overweight rating reaffirmed by analysts at Wells Fargo & Company. They currently have a $112.00 price target on the stock.

Prime Medicine (NYSE:PRME) had its buy rating reiterated by analysts at Guggenheim. The firm currently has a $18.00 price target on the stock.

Transocean (NYSE:RIG) had its hold rating reiterated by analysts at Benchmark Co..

Rallybio (NASDAQ:RLYB) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $5.00 price target on the stock.

Cartesian Therapeutics (NASDAQ:RNAC) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $41.00 target price on the stock.

Revolution Medicines (NASDAQ:RVMD) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $68.00 target price on the stock.

SentinelOne (NYSE:S) had its buy rating reiterated by analysts at Westpark Capital. The firm currently has a $34.00 price target on the stock.

Snap (NYSE:SNAP) had its buy rating reissued by analysts at Guggenheim. The firm currently has a $12.11 price target on the stock.

Snowflake (NYSE:SNOW) had its market outperform rating reiterated by analysts at JMP Securities. JMP Securities currently has a $190.00 price target on the stock.

Stevanato Group (NYSE:STVN) had its equal weight rating reissued by analysts at Morgan Stanley. They currently have a $23.00 target price on the stock, down from their previous target price of $24.00.

THOR Industries (NYSE:THO) had its hold rating reaffirmed by analysts at Benchmark Co..

TransMedics Group (NASDAQ:TMDX) had its outperform rating reaffirmed by analysts at Oppenheimer Holdings Inc.. They currently have a $125.00 target price on the stock.

TransMedics Group (NASDAQ:TMDX) had its hold rating reiterated by analysts at Needham & Company LLC.

TRX Gold (NYSE:TRX) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $1.50 price target on the stock, up from their previous price target of $1.40.

Workday (NASDAQ:WDAY) had its outperform rating reissued by analysts at Oppenheimer Holdings Inc.. The firm currently has a $300.00 price target on the stock.

Zscaler (NASDAQ:ZS) had its neutral rating reissued by analysts at Guggenheim.

Zscaler (NASDAQ:ZS) had its outperform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $230.00 target price on the stock.

Zscaler (NASDAQ:ZS) had its market outperform rating reissued by analysts at JMP Securities. JMP Securities currently has a $240.00 price target on the stock, down from their previous price target of $270.00.

Zscaler (NASDAQ:ZS) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $240.00 price target on the stock.